Literature DB >> 33025526

Eating disorders and the risk of developing cancer: a systematic review.

Nathalie Michels1, Fien De Backer2, Myrto Dimakopoulou3, Katerina Mane3, Iciar Indave3, Inge Huybrechts2,3.   

Abstract

PURPOSE: Evidence concerning eating disorders as risk toward developing cancer is sparse. Energy restriction might be cancer protective, while malnutrition, vomiting, laxative and substance use might stimulate cancer development. We examined whether individuals with an eating disorder (not restricted to anorexia nervosa) had a different risk of developing cancer.
METHODS: A systematic search on Medline and Embase until 28th April 2020 identified relevant human original research publications, including all populations and all cancer types.
RESULTS: From 990 records, 6 case reports and 9 cohorts were included. Some cohorts found a decreased breast (3/5 studies) or cervical (1/2) cancer risk, while an increased esophageal (2/3), liver (1/1), brain (1/1 in men) and respiratory (2/4) cancer risk, but other cancer risks were non-significant, and an increased mortality overall (1/2), from breast (1/1), female genital (1/1) and skin (1/1) cancer in eating disorder patients. The case reports further described esophageal cancer and leukemia. No clear statistical differences in cancer risk were found depending on eating disorder type, perhaps due to the small sample size (n = 1783 for other than anorexia nervosa).
CONCLUSIONS: The literature on eating disorders and cancer risk is sparse with many gaps. Hormonal changes, sexual activity, nutritional status, vomiting and concomitant tobacco/alcohol abuse may explain increased/decreased cancer risk. Future large studies (now 1-366 cancer cases) that also include men (now 4.7%), bulimia nervosa (now 3.8%) and several cancer sites (now mainly breast cancer) are needed and should foresee longer follow-up time (now 5.4-15.2 years) and extensive confounder adjustment (now only age and sex). LEVEL OF EVIDENCE: Level I, systematic review.

Entities:  

Keywords:  Anorexia nervosa; Bulimia nervosa; Neoplasms; Observational studies; Systematic review

Year:  2020        PMID: 33025526     DOI: 10.1007/s40519-020-01020-4

Source DB:  PubMed          Journal:  Eat Weight Disord        ISSN: 1124-4909            Impact factor:   4.652


  31 in total

1.  Bulimia nervosa as a risk factor for squamous cell carcinoma of the esophagus?

Authors:  Sophie Buyse; Stéphane Nahon; Thierry Tuszynski; Nicolas Delas
Journal:  Am J Gastroenterol       Date:  2003-06       Impact factor: 10.864

2.  Lasting influence of early caloric restriction on prevalence of neoplasms in the rat.

Authors:  M H Ross; G Bras
Journal:  J Natl Cancer Inst       Date:  1971-11       Impact factor: 13.506

Review 3.  Physiological effects of bulimia nervosa on the gastrointestinal tract.

Authors:  L Anderson; J M Shaw; L McCargar
Journal:  Can J Gastroenterol       Date:  1997 Jul-Aug       Impact factor: 3.522

4.  Body-mass index and mortality in a prospective cohort of U.S. adults.

Authors:  E E Calle; M J Thun; J M Petrelli; C Rodriguez; C W Heath
Journal:  N Engl J Med       Date:  1999-10-07       Impact factor: 91.245

Review 5.  Epidemiology of eating disorders in Europe: prevalence, incidence, comorbidity, course, consequences, and risk factors.

Authors:  Anna Keski-Rahkonen; Linda Mustelin
Journal:  Curr Opin Psychiatry       Date:  2016-11       Impact factor: 4.741

Review 6.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.

Authors:  Andrew G Renehan; Margaret Tyson; Matthias Egger; Richard F Heller; Marcel Zwahlen
Journal:  Lancet       Date:  2008-02-16       Impact factor: 79.321

Review 7.  Eating disorders.

Authors:  Janet Treasure; Angélica M Claudino; Nancy Zucker
Journal:  Lancet       Date:  2010-02-13       Impact factor: 79.321

8.  Barrett's esophagus and squamous cell carcinoma in a patient with psychogenic vomiting.

Authors:  Sophie Dessureault; Domenico Coppola; Michael Weitzner; Pauline Powers; Richard C Karl
Journal:  Int J Gastrointest Cancer       Date:  2002

9.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  BMJ       Date:  2009-07-21

10.  Esophageal cancer in a young woman with bulimia nervosa: a case report.

Authors:  Eric T Shinohara; Samuel Swisher-McClure; Michael Husson; Weijing Sun; James M Metz
Journal:  J Med Case Rep       Date:  2007-11-29
View more
  1 in total

1.  Understanding the use of evidence in the WHO Classification of Tumours: a protocol for an evidence gap map of the classification of tumours of the lung.

Authors:  Javier Del Aguila Mejía; Subasri Armon; Fiona Campbell; Richard Colling; Magdalena Chechlinska; Magdalena Kowalewska; Marina Pollán; Stefan Holdenrieder; Puay Hoon Tan; Ian Cree; Blanca Iciar Indave Ruiz
Journal:  BMJ Open       Date:  2022-10-11       Impact factor: 3.006

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.